Amplius Wealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Amplius Wealth Advisors's ABBV Position: Q3 2026 in Review
Amplius Wealth Advisors increased its AbbVie (ABBV) stake by 12% in Q3 2026, buying an estimated $101K and bringing the position to 3,636 shares worth $951K. The position accounts for 0.07% of the portfolio, ranked #84.
Amplius Wealth Advisors first reported a position in ABBV in Q4 2021 and has held it in 20 quarters since. The position peaked at $1.13M in Q4 2021. 1,443 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Amplius Wealth Advisors held 3,636 shares of AbbVie worth $951K as of Q3 2026.
- Amplius Wealth Advisors bought 395 AbbVie shares in Q3 2026, an estimated $101K.
- AbbVie made up 0.07% of Amplius Wealth Advisors's portfolio in Q3 2026, its #84 holding.
- Amplius Wealth Advisors first reported a position in AbbVie in Q4 2021 and has held it in 20 quarters since.
- Amplius Wealth Advisors's AbbVie position peaked at $1.13M in Q4 2021.
- 1,443 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Amplius Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.